Home › Funds › Vivo Capital, LLC › DTIL
Vivo Capital, LLC position in DTIL
Precision Biosciences Inc · Health Care
Vivo Capital, LLC reported holding 4,675 shares of DTIL (Precision Biosciences Inc) in its Q3 2026 13F filing — a position valued at US$29K, representing 0.00% of its reported portfolio and ranking #48 among its reported holdings. Vivo Capital, LLC has disclosed DTIL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Vivo Capital, LLC's DTIL position evolved
Vivo Capital, LLC first disclosed a stake in DTIL in Q3 2023 at 140,255 shares (US$48K). The position peaked in Q1 2024 at 4,675 shares, worth US$63K. Across 13 filings, Vivo Capital, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 4,675 shares valued at US$29K. Notable position changes include a 97% trim in Q1 2024 (shares fell 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 140.25K | $47.87K | New |
| Q4 2023 | 140.25K | $51.19K | Hold |
| Q1 2024 | 4.67K | $63.40K | Reduce |
| Q2 2024 | 4.67K | $45.49K | Hold |
| Q3 2024 | 4.67K | $41.89K | Hold |
| Q4 2024 | 4.67K | $17.81K | Hold |
| Q1 2025 | 4.67K | $22.30K | Hold |
| Q2 2025 | 4.67K | $19.64K | Hold |
| Q3 2025 | 4.67K | $25.81K | Hold |
| Q4 2025 | 4.67K | $19.45K | Hold |
| Q1 2026 | 4.67K | $25.71K | Hold |
| Q2 2026 | 4.67K | $36.75K | Hold |
| Q3 2026 | 4.67K | $29.27K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DTIL and 13F data
DTIL (Precision Biosciences Inc) is a Health Care company. 50 other funds we track also report a position in DTIL — the largest reported positions include Bleichroeder LP (US$12.6M), Octagon Capital Advisors LP (US$10.6M), Lynx1 Capital Management LP (US$7.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DTIL
- Bleichroeder LP 2.02M sh · $12.63M · Q3 2026
- Octagon Capital Advisors LP 1.35M sh · $10.61M · Q2 2026
- Lynx1 Capital Management LP 950.47K sh · $7.47M · Q2 2026
- Empery Asset Management, LP 776.09K sh · $6.10M · Q2 2026
- Velan Capital Investment Management LP 40.00K sh · $314.40K · Q2 2026
More on Vivo Capital, LLC
FAQ
How long has Vivo Capital, LLC held DTIL?
Vivo Capital, LLC has disclosed DTIL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Vivo Capital, LLC's current position in DTIL?
As of Q3 2026, Vivo Capital, LLC holds 4.67K shares of DTIL (Precision Biosciences Inc), valued at $29.27K, representing 0.00% of its reported portfolio and ranking #48.
Has Vivo Capital, LLC been buying or selling DTIL?
In the latest 13F filing (Q3 2026), Vivo Capital, LLC held unchanged its position in DTIL. The position peaked in Q1 2024 at 4.67K shares.
Which other funds hold DTIL?
Other major institutional holders of DTIL include Bleichroeder LP, Octagon Capital Advisors LP, Lynx1 Capital Management LP, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.